Pharma company faces UCPMP probe over Rs 1.91 Crore spent on Doctors' Travel - Video

Published On 2024-12-25T17:45:33+05:30 | Updated On 25 Dec 2024 5:45 PM IST

Overview

In a first of its kind case under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, the Apex Committee for Pharma Marketing Practices has issued a reprimand against AbbVie Healthcare India Private Ltd, a subsidiary of US-based AbbVie Inc., for unethical marketing practices. The company was allegedly found guilty of sponsoring international trips for nearly Rs 1.91 crore for 30 Healthcare Professionals (HCPs) under the pretense of professional development, contravening the UCPMP guidelines.

The case began with an anonymous complaint submitted to the Department of Pharmaceuticals (DoP) on May 21, 2024. The complaint, supported by internal company documents, alleged that AbbVie provided foreign travel and accommodation for 30 doctors attending the Aesthetics & Anti-Aging Medicine World Congress 2024 held in Monaco (February 1–3, 2024) and Paris (March 26–29, 2024). The alleged expenses totaled Rs 1.91 crore, covering flights and hotel stays.

For more information, click on the link below:

Rs 1.91 Crore spent on Doctors Travel: Pharma Company faces UCPMP heat, soon action against 30 doctors

Speakers

Yakshi Chugh

With a graduation in Journalism and Mass Communication from Amity University, Yakshi Chugh embarked on a journey to explore the dynamic intersection of media and healthcare. In 2024, she joined Medical Dialogues, driven by a passion to enhance healthcare journalism and deliver insightful, impactful content to readers.